Skip to main content
. 2022 Dec 27;8(6):491–496. doi: 10.33546/bnj.2230

Table 3.

The details of the final nursing outcome quality indicators for patients with ischemic stroke receiving thrombectomy treatment in each component

No. Indicator detail Median IQR The percentage of answers change
1. Nursing outcome quality indicators for patients with ischemic stroke before receiving thrombectomy treatment
1.1 Patients and relatives don’t have anxiety after preparing readiness for physical and psychological perspectives. 5 1 10.53
1.2 Patients and relatives understand the usefulness, risk, and complication that may happen during and after thrombectomy treatment. 5 1 5.26
1.3 Patients and relatives understand the practical during and after thrombectomy treatment. 5 1 10.53
1.4 No abnormality of vital signs before thrombectomy treatment, especially blood pressure, should be ≤ 185/110 mmHg. 5 1 10.53
1.5 A history of taking an allergy to medication, seafood, and contrast to prevent a contrast allergy. 5 0 0
2. Nursing outcome quality indicators for patients with ischemic strokeduring receiving thrombectomy treatment
2.1 No complications from cardiac arrhythmias, such as atrial fibrillation and acute myocardial infarction, by monitoring the rate and rhythm of the heartbeat by ECG monitoring. 5 0 10.53
2.2 No contrast allergy after injecting to the artery, such as skin rash, urticaria, itching, edema around the eyes, edema under the skin, larynx swelling, shallow breathing, etc. 5 0 10.53
2.3 No abnormality of vital signs or neurological signs during thrombectomy treatment by measuring a vital sign every 15 minutes. 5 0 5.26
2.4 No vasospasm after receiving intravenous nimodipine by measuring blood pressure every 5 minutes. 5 0 5.26
2.5 No cyanosis during thrombectomy treatment by assessing oxygen saturation ≥ 95% 5 0 5.26
2.6 No contrast-induced acute kidney injury during thrombectomy treatment by assessing signs and symptoms such as oliguria, hypertension, edema, heart congestion, pulmonary edema, etc. 5 0 10.53
3. Nursing outcome quality indicators for patients with ischemic stroke after receiving thrombectomy treatment
3.1 No hemorrhage and hematoma at the catheter site within 1-3 days. 5 0.75 0
3.2 No peritonitis by assessing signs and symptoms such as abdominal pain, guarding, back pain, nausea, vomiting, etc. 5 0.75 0
3.3 No brain hemorrhage after receiving thrombectomy treatment by assessing neurological signs. 5 0 10.53
3.4 No change of neurological signs, such as no decrease of GCS ≥ 1 score; pupils show equal size, shape, and reaction in both sizes. 5 0.75 10.53
3.5 No complication of hypertension by controlling systolic blood pressure = 90-139 mmHg and DBP = 60-89 mmHg. 5 0.75 0
3.6 No complication from blood glucose changes by hypoglycemia; blood sugar < 80 mg%, hyperglycemia; blood sugar > 160 mg% after controlling blood glucose as prescribed. 5 0 0
3.7 Receiving assessment of headache and projectile vomiting to prevent brain edema. 5 0 5.26
3.8 Receiving assessment of headache, projectile vomiting, and crushing’s triad to prevent increased intracranial pressure. 5 0 5.26
3.9 No limb ischemia by palpating the pulse at the dorsalis pedis or posterior tibial on both sides compared to before and after the treatment. 5 0 10.53
3.10 No deep vein thrombosis by assessing pale skin, leg pain, edema, cold toes, etc. 5 0 10.53
3.11 No contrast-induced acute kidney injury after recording body intake and output and monitoring BUN, Cr within 48-72 hours. 5 0 10.53
3.12 No delay in administering antiplatelet via a nasogastric tube in case of patient inserts a stent with blood vessel occlusion. 5 0 10.53
3.13 No body infection such as pneumonia, catheter-associated urinary tract infection (CAUTI), or sepsis by controlling body temperature < 37.5oC 5 0 5.26
3.14 No pressure sore by turning the position every 2 hours. 5 0 10.53
3.15 Patient and relative understand the self-care for preparing readiness of discharge following D-METHOD-P 5 0 10.53
3.16 Patients and relatives understand and give the importance of taking an antiplatelet, anticoagulant, or underlying disease medication when discharged from the hospital. 5 0 10.53
3.17 No progressive stroke in a patient with NIHSS ≥ 4 scores after monitoring and caution following the organization. 5 0 0